SEC Filings

S-1
AVEXIS, INC. filed this Form S-1 on 01/15/2016
Entire Document
 

 

APPENDIX I

AskBio Patent Rights

 

Self-Complementary Patent Rights:

 

Status

 

Country

 

Filing Date

 

Priority
Date

 

Number

 

Patent or
Publication
Number

 

Issue Date

 

Expiration
Date

****

 

****

 

****

 

 

 

****

 

 

 

 

 

 

****

 

****

 

****

 

****

 

****

 

****

 

****

 

 

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

****

 

****

 

****

 

****

 

****

 

****

 

****

 

****

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

 

****

 

****

 

 

 

****

 

****

 

 

 

 

 

Hybrid Patent Rights

 

The following foreign patents include claims directed to AskBio’s Chimeric Vector Technology, which claims are expressly excluded from the definition of “AskBio Patent Rights” and no right or license is granted in or to such AskBio Chimeric Vector Technology claims under this Agreement.  For the avoidance of doubt, the specific claims that are included in the license grant are listed below.

 


****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.  CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 



© AveXis, Inc. All Rights Reserved.